GLP-1 & weight-management formulations · Wichita, Kansas
Daily sublingual GLP-1 in Wichita
Daily sublingual (SL) oral GLP-1 formulations. Prepared through Hart Pharmacy & Home Medical Equipment with a valid prescription and clinical review.
Availability & preparation
Hart offers daily sublingual glp-1 as part of our glp-1 & weight-management formulations services. Each preparation is reviewed for the individual prescription and applicable regulations. Offered does not mean immediately in stock.
Call 316-683-5621 to confirm the prescribed ingredients, strength, dosage form, pricing and preparation time. Our pharmacy can also review transfer eligibility with your current pharmacy and prescriber.
Dosing & administration
Prescribed schedule: daily sublingual (sl).
This offering uses a daily sublingual (SL) schedule, with administration under the tongue as directed on your prescription. Your prescriber selects the medication, strength, amount and any titration. Follow the pharmacist's preparation-specific instructions; do not substitute injectable dosing.
There is no single dose for every patient. The amount, concentration, frequency and any changes must follow your prescription and clinician’s instructions. This page does not provide an individual dosing recommendation.
Discuss with your pharmacist
- Confirm the medication, prescribed strength and injectable or sublingual route.
- Review the starting dose and any clinician-directed titration.
- Ask about administration, storage, refill timing and monitoring.
For a private discussion of your prescription or medical history, call our pharmacy. Do not send patient health information through the website contact form.
Your local Wichita compounding pharmacy
Visit Hart’s public pharmacy at 6217 E 13th St N, Wichita, KS 67208 for prescription questions and pickup. Ask about free once weekly local prescription delivery or Kansas shipping options; arrangements are confirmed for your prescription.
Compounded medications are not FDA-approved and are not automatically equivalent to an approved medicine or another pharmacy’s preparation. A change of formulation requires clinical review. Other peptides are coming soon, not currently offered.
